Convalescent Plasma Donation and COVID-19
We are screening all eligible donors for COVID-19 antibodies.
Your test results can be accessed via our Donor Portal.
The test is authorized by the FDA and detects if you have developed antibodies to COVID-19. The antibody test is not a diagnostic test and will not indicate if you currently have COVID-19.
If you feel you may have COVID-19, please do not donate at this time, and come back when you are symptom free.
For FAQ about antibody testing, click here.
COVID-19 Vaccine and Donating
After receiving the vaccine, can I donate blood? Yes. If you received the Pfizer or Moderna vaccines, there is no deferral for blood donation. If you can’t remember or it was another manufacturer, there is a two-week deferral. The list of vaccines and eligibility will be updated regularly as new vaccines receive approval.
Why is donating convalescent plasma important?
There are no FDA approved treatments currently available for severe cases of COVID-19.
Convalescent plasma has shown positive results in previous disease outbreaks, such as H1N1, influenza, and Ebola.
While investigational, convalescent plasma shows promise as an effective treatment in early available data.
If you have recovered from COVID-19, and would like to donate convalescent plasma, please make an appointment to donate HERE.
Click here for the answers to frequently asked questions about coronavirus and blood donation!
As concern surrounding the impact of coronavirus increases, LifeSouth assures the community that it is safe to donate blood and encourages donors to help maintain a safe and adequate blood supply.
A sharp decline in donations is already being felt due to concerns about the virus. Although individuals are not at risk of contracting the coronavirus through the blood donation process, LifeSouth is taking every precaution to minimize the risk to donors. Blood donations are needed every day, and anyone who is in good health is encouraged to give.
“Respiratory viruses like COVID-19 are not known to be transmitted by blood transfusion and no cases of transfusion transmitted coronaviruses have been reported,” said Dr. Chris Lough, vice president of medical services for LifeSouth. “The most significant risk to the blood supply posed by COVID-19 is a lack of availability due to a decrease in donations.”
Hospitals have begun to voice concern due to a strained blood supply. Donating ensures that the community blood supply remains stable as the virus spreads, travel bans increase and the ongoing impact of the current flu season affects the number of donors able to give. LifeSouth, along with the AABB and America’s Blood Centers, urges businesses, schools, churches and community organizations to continue to hold blood drives and encourage blood donation.